We are seeking an ambitious researcher to join the Cancer Genome Variation group at the Oslo University Hospital. The position will be associated with the research group ''Cancer Genome Variation'' , and will be working on the pink ribbon funded research project “Towards Precision Approaches in Breast Cancer: Decoding Germline and Somatic Interactions “. The position is for 3 years, from 1st of August 2026. Start date is negotiable.
The Department of Medical Genetics at Oslo University Hospital is Norway’s largest medical genetics department with over 200 employees. The department is responsible for diagnostics of rare and inherited diseases, and runs a national research infrastructure for high-throughput DNA sequencing at the Norwegian Consortium for Sequencing and Personalized Medicine (www.norseq.org ). The research section in the department has 7 research groups (www.ous-research.no/meg/) working in various fields of medical genetics, including breast cancer, the genetics of autoimmune, neurological, cardiovascular and psychiatric disorders, epigenetics causes of disease, as well as groups focusing on bioinformatics.
Oslo University Hospital is a workplace with great diversity. We believe this is crucial for solving our tasks in the best possible way. We want this diversity to be reflected among the applicants for our positions, and we encourage all qualified candidates, regardless of background, to apply!
We are looking for a highly motivated, well organized and dynamic applicant with a high level of independence and creative thinking. The current position aims to increase our understanding of breast cancer genomic susceptibility to facilitate better prevention. The successful candidate will play a key role in a high-impact research project dedicated to advancing precision medicine in breast cancer.
This position focuses on bridging the gap between inherited genetic predisposition and the later acquisition of somatic mutations to better understand how breast cancer develops across the lifespan. By leveraging large-scale genomic and omic datasets, you will work to identify and characterize the biological mechanisms that drive disease risk, including the functional impact of genetic variants.
Work location will be at the Department of Medical Genetics, Section for Research and Development. In early 2027, our department will move to the new
Life Science building, providing the applicant the exciting opportunity to work in Norway’s largest and most modern research building.Links
Cancer genome variation:
https://ous-research.no/kristensen/Life Science building: https://www.uio.no/english/research/strategic-research-areas/life-science/about/building/
Ina S. Brorson, Project leader/Researcher, i.s.brorson@medisin.uio.no
Kirkeveien 166
0450 Oslo
Arbeidsgiver: Oslo universitetssykehus HF
Referansenr.: 5118534712
Stillingsprosent: 100%
Contract
Startdato: 01.08.2026
Sluttdato: 31.08.2029
Søknadsfrist: 11.05.2026
Oslo University Hospital is a highly specialized hospital in charge of extensive regional and local hospital assignments. As Scandinavia’s largest hospital, we carry out more than 1.2 million patient treatments each year. The hospital has a nationwide responsibility for a number of national and multi-regional assignments, and has several national centers of competence. Oslo University Hospital is responsible for approximately 50 percent of all medical and health care research conducted at Norwegian hospitals, and is a significant role player within the education of a large variety of health care personnel.